Timeline

How open innovation advanced pancreatic cancer research 

The journey of our glucocorticoid receptor agonist and how it impacted independent research 

Live Online Seminar. Tom is one of the speakers (24.06.2025)

The website announces an online seminar on June 24, 2025, on the glucocorticoid receptor and its role in pancreatic cancer, with Thomas Ekstrom as the keynote speaker.

Watch here

EMBO Workshop: Enhancer Mechanics and Enhanceropathies, Middelfart, Denmark: Yara and Akshay participated (16.-20.06.2025)

SLAS Europe 2025 Conference and Exhibition, Hamburg: Karoline is representing the RBCT (21.-22.05.2025)

Gordon Research Conference, Cancer Genetics and Epigenetics, Decoding the Cancer Genome and Epigenome, Lucca (Italy): Sven is representing the RBCT (18.-23.05.2025)

Karoline is visiting the International Helmholtz Drug Discovery Conference in Berlin (28.04.2025)

AACR Annual Meeting 2025, Chacago, Illinois,Robyn, Dominik, Onur and Patricia are representing RBCT (25.04.2025)

CCC-N Young Cancer Scientist Symposium 2025, Goettingen, Zeynab represented RBCT as an invited speaker. 👏 (25.04.2025)

3R-Network BW Annual Conference 2025, Stuttgart, Teodora, Patricia, Vera, Jacqueline, Prashanthi, Onur and Subhiksha are representing RBCT

European Lung Cancer Congress (ELCC), Paris, Sandra is representing the RBCT (26.03.2025)

Sneha Sahadevan defended her Master Thesis (23.03.2025)

22nd International AEK Cancer Congress, Berlin, Steve and Akshay are representing the RBCT (05.03.2025)

Joana Aggrey-Fynn defended her PhD Thesis (18.03.2025)